Changhui Wu

Changhui Wu

Auto-generated profile, based on publicly available information

Changhui Wu

China Pharmaceutical University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2024 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
YYYiming Yang
Yiming Yang
CWChanghui Wu
Changhui Wu
JXJunhao Xing
Junhao Xing
XDXiaowei Dou
Xiaowei Dou

21 March 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
LYLong Yin
Long Yin
JLJiajia Li
Jiajia Li
CWChanghui Wu
Changhui Wu
HZHaoran Zhang
Haoran Zhang
WZWenchao Zhao
Wenchao Zhao
DGDong Guo
Dong Guo
The importance of P-stereogenic heterocycles has been widely recognized with their extensive use as privileged chiral ligands and bioactive compounds. The catalytic asymmetric synthesis of P-stereogenic phosphindane derivatives, however, remains a challenging task. Herein, we report a catalytic kinetic resolution of phosphindole oxides via rhodium-catalyzed diastereo- and enantioselective conjugate addition to access enantiopure P-stereogenic phosphindane and phosphindole derivatives. This kinetic resolution method features high efficiency (s factor up to >1057), excellent stereoselectivities (all >20:1 dr, up to >99% ee), and a broad substrate scope. The obtained chiral phosphindane oxides exhibit promising therapeutic efficacy in autosomal dominant polycystic kidney disease (ADPKD), and compound 3az is found to significantly inhibit renal cyst growth both in vitro and in vivo, thus ushering in a promising scaffold for ADPKD drug discovery. This study will not only advance efforts towards the asymmetric synthesis of challenging P-stereogenic heterocycles, but also surely inspire further development of P-stereogenic entities for bioactive small-molecule discovery.

10 January 2025 in Organic Letters
Verified
Journal Article
Closed access
CPChuanyong Peng
Chuanyong Peng
CWChenhong Wang
Chenhong Wang
CWChanghui Wu
Changhui Wu
JXJunhao Xing
Junhao Xing
FXFei Xue
Fei Xue
XDXiaowei Dou
Xiaowei Dou

18 May 2024 in Phytochemistry
Verified
Journal Article
Closed access
HSHongjie Shao
Hongjie Shao
YLYe Li
Ye Li
CWChanghui Wu
Changhui Wu
RCRuoyun Chen
Ruoyun Chen
JKJie Kang
Jie Kang

12 December 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
JZJing Zhong
Jing Zhong
MLMengxian Li
Mengxian Li
CWChanghui Wu
Changhui Wu
HLHui Li
Hui Li
HDHongyue Dong
Hongyue Dong
HYHequan Yao
Hequan Yao
Bridged-ring scaffolds are prevalent in numerous natural products and pharmaceuticals. However, achieving enantioselective construction of these architectures presents a significant challenge, due to the considerable structural strain of the products and the presence of multiple stereocenters. Herein, we report a Pd/Cu co-catalyzed substrate-dependent enantiodivergent tandem Heck/Sonogashira reaction for the synthesis of alkyne-tethered (R,S,S)-bicyclo[3.2.1]octenes and (S,R,R)-benzo-bicyclo[3.2.1]octanes, each featuring one quaternary and two adjacent tertiary stereocenters. Intramolecular cyclization of the resultant bridged-ring skeletons facilitates the stereospecific synthesis of rigid chiral tricyclodecanes and tetracyclotetradecanes. The alkene, alkyne and ester motifs within bicyclo[3.2.1]octenes and benzo-bicyclo[3.2.1]octanes enables a diverse of transformations, providing access to versatile bridged-ring compounds. Preliminary activity assays demonstrate that two of chiral bridged-ring compounds display good inhibitory effects on the cGAS-STING signaling pathway. Mechanistic studies and DFT calculations indicate that reductive elimination is the rate-determining step in tandem Heck/Sonogashira reaction. Furthermore, key factors responsible for the substrate-dependent enantiodivergence are elucidated through DFT calculations.

29 June 2023 in Chemical Science
Verified
Journal Article
Open access
PDF file
CWChanghui Wu
Changhui Wu
ZCZhiqian Chang
Zhiqian Chang
CPChuanyong Peng
Chuanyong Peng
CBChen Bai
Chen Bai
JXJunhao Xing
Junhao Xing
XDXiaowei Dou
Xiaowei Dou
A new catalytic asymmetric indolization reaction was developed, and the optimal catalyst was identified based on a quantitative structure–selectivity relationship model.